Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stockhorst, U.
Right arrow Articles by Gries, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stockhorst, U.
Right arrow Articles by Gries, F. A.
Related Collections
Right arrow Endocrinology
Right arrow Nutrition

Classical Conditioning of Insulin Effects in Healthy Humans

Ursula Stockhorst, PhD, Eva Gritzmann, Kerstin Klopp, Yolanda Schottenfeld-Naor, MD, Achim Hübinger, MD, Hans-Walter Berresheim, Cert. Eng., Hans-Joachim Steingrüber, PhD and Friedrich Arnold Gries, MD

From the Institute of Medical Psychology (U.S., E.G., K.K., H.-J.S.), Diabetes Research Institute (Y.S.-N., A.H., F.A.G), and Medical Institute of Environmental Hygiene (H.-W.B.), Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.



View larger version (25K):

[in a new window]
 
Fig. 1. Time schedule of each experimental session on 5 consecutive days. Go

indicates times at which 20 ml of blood was drawn to measure levels of insulin (INS), glucagon, adrenaline, noradrenaline, and cortisol at minutes -24, 24, 48, and 72. Go

indicates times at which 20 µl of blood was drawn for measurement of blood glucose. CS = conditioned stimulus; S = symptom list; SP = substance perception; Min* = minutes relative to injection.

 


View larger version (32K):

[in a new window]
 
Fig. 2. Blood glucose (mg/dl) on days 1 to 4 of the acquisition phase. Mean (M) and SEM values are shown for groups 1 and 2. Injection was given immediately after blood sampling at minute 0.

 


View larger version (28K):

[in a new window]
 
Fig. 3. Blood glucose change (mg/dl) relative to mean (M) baseline level during the test phase (day 5) under CS–saline in groups 1 and 2. Top, Cumulative change over the 13 post-CS measurement points (mean ± SEM). Baseline level is also shown. Bottom, Change per measurement point. Pre-CS measurements (minutes -24 to -6) are interconnected by dotted lines; post-CS measurements are interconnected by solid lines. Results of descriptively conducted Mann-Whitney U tests: [*] = p < .10; * = p < .05.

 


View larger version (28K):

[in a new window]
 
Fig. 4. Insulin and cortisol on days 1 to 5 in groups 1 and 2. Left, Insulin change (mU/liter). Difference from baseline value (minute -24). Mean (M) and SEM values are given. Baseline (BA) values are also shown. See break of y axis at day 5. Right, Cortisol change (µg/dl). Difference from baseline value (minute -24). Mean and SEM values are given. BA values are also shown. See break of y axis at day 5. Results of descriptively conducted Mann-Whitney U tests: [*] = p < .10; * = p < .05; *** = p < .001.

 


View larger version (41K):

[in a new window]
 
Fig. 5. Number of symptoms. Difference from baseline value (minute -24) on days 1 to 5 in groups 1 ({blacksquare}) and 2 ({circ}). Mean (M) ± SEM baseline (BA) values are given. Left, Neuroglycopenic score. Middle, Autonomic score. Right, Total number of symptoms score. Mean ± SEM values are given. Results of descriptively conducted Mann-Whitney U tests: [*] = p < .10; * = p < .05; ** = p < .01; *** = p < .001.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Psychosomatic Society